Sodium Fluoride F 18
Generic: SODIUM FLUORIDE F 18
Basic Information
Manufacturer
Mayo Clinic
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS
FDA Set ID
e435568c-f8d2-4cee-aceb-c68b277ad8f5
Indications & Usage
1 INDICATIONS AND USAGE Sodium Fluoride F 18 Injection USP is indicated for diagnostic positron emission tomography (PET) imaging of bone to define areas of altered osteogenic activity.
Sodium Fluoride F 18 Injection USP is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity ( 1 ).
Sodium Fluoride F 18 Injection USP is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity ( 1 ).
Adverse Reactions
6 ADVERSE REACTIONS No adverse reactions have been reported for Sodium Fluoride F 18 Injection USP based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems.
However, the completeness of these sources is not known.
No adverse reactions have been reported for based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems ( 6 ).
To report SUSPECTED ADVERSE REACTIONS, contact Division of Nuclear Medicine, Department of Radiology, Mayo Clinic at 507-284-2511 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
However, the completeness of these sources is not known.
No adverse reactions have been reported for based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems ( 6 ).
To report SUSPECTED ADVERSE REACTIONS, contact Division of Nuclear Medicine, Department of Radiology, Mayo Clinic at 507-284-2511 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.